​In response to the global epidemic COVID-19 and the shortage of medical masks worldwide, we received support from Livzon Pharmaceutical Group Inc. to negotiate the procurement of rapid diagnostic test for "New Coronavirus (2019) -nCoV) IgM/IgG Antibody", which is used to qualitatively detect the IgM/IgG antibodies in human serum, plasma and other samples in vitro, to help with fighting the epidemic.